R. Dowey

发表

Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the protein kinase C inhibitor ruboxistaurin

E. Kiss-Toth, J. Cole, A. Condliffe, 2022, ERJ Open Research.

Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the PKC inhibitor ruboxistaurin.

R. Hull, E. Kiss-Toth, K. Bradley, 2021, medRxiv.

Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial

Robert J. Mackenzie, Patrick M Liu, M. Haynes, 2022, The Lancet Respiratory Medicine.

A Bittersweet Response to Infection in Diabetes; Targeting Neutrophils to Modify Inflammation and Improve Host Immunity

S. Heller, L. Prince, I. Sabroe, 2021, Frontiers in Immunology.